VIALOGY PLC |
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| 2023 | Yourgene Health Delists Following Novacyt Acquisition | MT |
| 2023 | Novacyt: Yourgene officially delisted in London | CF |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
More news
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Lyn Rees
CEO | Chief Executive Officer | 51 | 18-07-03 |
Peter Charles
DFI | Director of Finance/CFO | - | 23-03-16 |
Bill Chang
BRD | Director/Board Member | 49 | 17-02-26 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
John Brown
CHM | Chairman | 69 | 19-07-28 |
Lyn Rees
CEO | Chief Executive Officer | 51 | 18-07-03 |
Barry Hextall
SEC | Corporate Secretary | 56 | 15-06-03 |
Yourgene Health PLC is an integrated molecular diagnostics company. The Company primarily develops, manufactures, and commercializes molecular diagnostic solutions for reproductive health, precision medicine and infectious diseases. Its segments include Genomic Technologies, which provides in vitro diagnostic products, software and instrumentation, and Genomic Services, which provides services to clinicians, third party clinical service providers and contract research organizations. Its flagship products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, and an extension into the precision medicine space with DPYD genotyping. It has a range of deoxyribonucleic (DNA) sample preparation platforms, powered by Ranger Technology, the Yourgene LightBench and Yourgene QS250, ideal for cell-free DNA applications in non-invasive prenatal tests and oncology, including liquid biopsy.
Sector
-